Loading...

Home
Stock
DNLI

DNLI News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Stock Price Prediction Technical Valuation Financials Earnings Should I Buy News & Events

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

DNLI News

Relmada Therapeutics Shares Surge 40.8% on Promising Trial Data

Mar 09 2026Benzinga

FDA Rejects Multiple Experimental Drug Applications, Raising Investor Concerns

Mar 06 2026CNBC

FDA Drug Approval Uncertainty Intensifies

Mar 06 2026Newsfilter

Denali Therapeutics Reports Q4 Results and Stock Offering

Feb 26 2026seekingalpha

Shifting Trends in Biotechnology Mergers and Acquisitions

Feb 19 2026Globenewswire

REGENXBIO Faces FDA Challenges for Gene Therapy Approval

Feb 10 2026Newsfilter

REGENXBIO's RGX-121 BLA Accepted by FDA Under Accelerated Approval Pathway

Feb 10 2026Benzinga

Denali Therapeutics Advances in Hunter Syndrome Treatment

Feb 05 2026Newsfilter

DNLI Events

No data

No data

DNLI Monitor News

Denali Therapeutics Inc Stock Declines Amid Market Weakness

DNLI Earnings Analysis

No Data

No Data

People Also Watch